Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Ugur, Gezer"'
Publikováno v:
Cell Journal, Vol 24, Iss 12, Pp 774-778 (2022)
Prostate cancer (PCa) is a common malignant disease with high mortality rates that develops and progresses in anandrogen-dependent way. In recent years, RNA sequencing enabled identification of many PCa-related long noncodingRNAs including androgen r
Externí odkaz:
https://doaj.org/article/d7b4211d9ecb469f887fcde43fae717a
Autor:
Ugur Gezer, Angela Oberhofer, Karolina Worf, Oliver Stoetzer, Stefan Holdenrieder, Abel Bronkhorst
Publikováno v:
Diagnostics, Vol 14, Iss 6, p 609 (2024)
Liquid biopsies are revolutionizing the detection and management of malignant diseases. While repetitive DNA sequences, such as LINE-1 and ALU are established in cell-free DNA (cfDNA) research, their clinical applications remain limited. In this stud
Externí odkaz:
https://doaj.org/article/41b1474cd01b41d6b50bc765749a810f
Publikováno v:
Diagnostics, Vol 12, Iss 12, p 3042 (2022)
Breast cancer is the most common cancer affecting women worldwide. It is a malignant and heterogeneous disease with distinct molecular subtypes, which has prognostic and predictive implications. Circulating tumor DNA (ctDNA), cell-free fragmented tum
Externí odkaz:
https://doaj.org/article/db75e1f222ec4daeba7d48e45e4a565c
Publikováno v:
Diagnostics, Vol 12, Iss 6, p 1363 (2022)
Liquid biopsy is a broad term that refers to the testing of body fluids for biomarkers that correlate with a pathological condition. While a variety of body-fluid components (e.g., circulating tumor cells, extracellular vesicles, RNA, proteins, and m
Externí odkaz:
https://doaj.org/article/8ee971ece0594a9c9eabd655e6ad57b2
Publikováno v:
Cell Journal, Vol 16, Iss 4, Pp 488-493 (2015)
Objective: Prostate cancer antigen 3 (PCA3) and microRNA-141 (miR-141) are emerging molecules in prostate cancer (PCa) pathogenesis and have been shown to be involved in androgen signaling. In this original research, we designed an experimental cell
Externí odkaz:
https://doaj.org/article/ec8f19c000ef49fbb3f6ae21b7bcc820
Autor:
Ugur Gezer, Emre Özgür
Publikováno v:
Bratislava Medical Journal. 121:362-365
OBJECTIVES In the present study, cellular or exosomal expression of H19, an oncofetal lncRNA gene, was evaluated during androgen stimulation via dihydrotestosterone (DHT) or AR blockage via enzalutamide in cultured hormone-sensitive Pca cells which o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2fe4200965c537ad57dec55adf17f7c
https://doi.org/10.4149/bll_2020_058
https://doi.org/10.4149/bll_2020_058
Liquid biopsy is a broad term that refers to the testing of body fluids for biomarkers that correlate with a pathological condition. While a variety of body-fluid components (e.g., circulating tumor cells, extracellular vesicles, RNA, proteins, and m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6d5641798f887f409d92b7a7cf29004
https://mediatum.ub.tum.de/doc/1685311/document.pdf
https://mediatum.ub.tum.de/doc/1685311/document.pdf
Publikováno v:
Turk J Gastroenterol
Background Gastric cancer (GC) is a common cause of cancer-related deaths. The poor clinical outcome in GC patients is partially associated with a lack of appropriate diagnostic and prognostic biomarkers. In the present study, we evaluated the diagno
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fcca5901defb19f99966155556edd3ae
https://europepmc.org/articles/PMC8975294/
https://europepmc.org/articles/PMC8975294/
Publikováno v:
Cancer Biomarkers. 27:11-17
Background Novel biomarkers are needed to predict the effectiveness of the treatment of presurgical neoadjuvant chemotherapy (NAC) in breast cancer (BC). Objective This is an exploratory study to assess the impact of 3 cancer-related long non-coding
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::865427649b38ef90da31c7075cb57be0
https://doi.org/10.3233/cbm-190085
https://doi.org/10.3233/cbm-190085
Publikováno v:
Cancer Biomarkers. 25:177-184
Background Reseptor tyrosine kinases (cMET and EGFR) are important in lung cancer targeted therapy. We believe if we can use them as markers for clinicians to help decide the diagnosis of lung cancer. This parameter will be important in serum samples
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::443a0fcdf84db42e8957c28f43856f59
https://doi.org/10.3233/cbm-182231
https://doi.org/10.3233/cbm-182231